CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-17 | Milligan John C.K. IV President/Secretary | Grant or award · Non-Qualified Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2015-12-17 | Krassan Mitchell EVP, Chief Strategy Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2015-08-25 | Russell Angus C. Director | Purchase | +13,500 | $5.98 | $81K | 48,500 |
| 2015-08-20 | Thompson Tommy G Director | Purchase | +455 | $6.29 | $3K | 1,000 |
| 2015-08-20 | Thompson Tommy G Director | Purchase | +343 | $6.29 | $2K | 1,000 |
| 2015-08-20 | Thompson Tommy G Director | Purchase | +10,000 | $6.29 | $63K | 10,000 |
| 2015-06-08 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion | +30,000 | $0.20 | $6K | 30,000 |
| 2015-06-08 | Krassan Mitchell EVP, Chief Strategy Officer | Sale | −30,000 | $8.18 | $245K | 0 |
| 2015-06-08 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 683,955 | ||
| 2015-05-20 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion | +60,000 | $0.19 | $11K | 60,000 |
| 2015-05-20 | Krassan Mitchell EVP, Chief Strategy Officer | Sale | −60,000 | $6.56 | $393K | 0 |
| 2015-05-20 | Krassan Mitchell EVP, Chief Strategy Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −60,000 | 105,703 | ||
| 2015-05-12 | Russell Angus C. Director | Purchase | +35,000 | $6.15 | $215K | 35,000 |
| 2015-05-11 | Thompson Tommy G Director | Purchase | +3,000 | $6.09 | $18K | 661,257 |
| 2015-05-11 | Thompson Tommy G Director | Purchase | +3,000 | $6.09 | $18K | 3,555 |
| 2015-05-08 | CARROLL J MARTIN Director | Purchase | +10,000 | $6.11 | $61K | 10,000 |
| 2015-03-25 | Thompson Tommy G Director | Grant or award · Non-qualified stock option | +125,000 | 125,000 | ||
| 2015-03-25 | Russell Angus C. Director | Grant or award · Non-qualified stock option | +100,000 | 100,000 | ||
| 2015-03-25 | CARROLL J MARTIN Director | Grant or award · Non-qualified stock option | +100,000 | 100,000 | ||
| 2015-03-25 | SEGAL NICHOLAS Director | Grant or award · Non-qualified stock option | +100,000 | 100,000 |
Page 26 of 33 · 642 trades